Near real-time surveillance of the SARS-CoV-2 epidemic with incomplete data.

When responding to infectious disease outbreaks, rapid and accurate estimation of the epidemic trajectory is critical. However, two common data collection problems affect the reliability of the epidemiological data in real time: missing information on the time of first symptoms, and retrospective revision of historical information, including right censoring. Here, we propose an approach to construct epidemic curves in near real time that addresses these two challenges by 1) imputation of dates of symptom onset for reported cases using a dynamically-estimated "backward" reporting delay conditional distribution, and 2) adjustment for right censoring using the NobBS software package to nowcast cases by date of symptom onset. This process allows us to obtain an approximation of the time-varying reproduction number (Rt) in real time. We apply this approach to characterize the early SARS-CoV-2 outbreak in two Spanish regions between March and April 2020. We evaluate how these real-time estimates compare with more complete epidemiological data that became available later. We explore the impact of the different assumptions on the estimates, and compare our estimates with those obtained from commonly used surveillance approaches. Our framework can help improve accuracy, quantify uncertainty, and evaluate frequently unstated assumptions when recovering the epidemic curves from limited data obtained from public health systems in other locations.

Trypanosoma cruzi vaccine candidate antigens Tc24 and TSA-1 recall memory immune response associated with HLA-A and -B supertypes in Chagasic chronic patients from Mexico.

Trypanosoma cruzi antigens TSA-1 and Tc24 have shown promise as vaccine candidates in animal studies. We evaluated here the recall immune response these antigens induce in Chagasic patients, as a first step to test their immunogenicity in humans. We evaluated the in vitro cellular immune response after stimulation with recombinant TSA-1 (rTSA-1) or recombinant Tc24 (rTc24) in mononuclear cells of asymptomatic Chagasic chronic patients (n = 20) compared to healthy volunteers (n = 19) from Yucatan, Mexico. Proliferation assays, intracellular cytokine staining, cytometric bead arrays, and memory T cell immunophenotyping were performed by flow cytometry. Peripheral blood mononuclear cells (PBMC) from Chagasic patients showed significant proliferation after stimulation with rTc24 and presented a phenotype of T effector memory cells (CD45RA-CCR7-). These cells also produced IFN-γ and, to a lesser extent IL10, after stimulation with rTSA-1 and rTc24 proteins. Overall, both antigens recalled a broad immune response in some Chagasic patients, confirming that their immune system had been primed against these antigens during natural infection. Analysis of HLA-A and HLA-B allele diversity by PCR-sequencing indicated that HLA-A03 and HLA-B07 were the most frequent supertypes in this Mexican population. Also, there was a significant difference in the frequency of HLA-A01 and HLA-A02 supertypes between Chagasic patients and controls, while the other alleles were evenly distributed. Some aspects of the immune response, such as antigen-induced IFN-γ production by CD4+ and CD8+ T cells and CD8+ proliferation, showed significant association with specific HLA-A supertypes, depending on the antigen considered. In conclusion, our results confirm the ability of both TSA-1 and Tc24 recombinant proteins to recall an immune response induced by the native antigens during natural infection in at least some patients. Our data support the further development of these antigens as therapeutic vaccine against Chagas disease.

Sustainable remediation of mercury contaminated soils by thermal desorption.

Mercury soil contamination is an important environmental problem that needs the development of sustainable and efficient decontamination strategies. This work is focused on the application of a remediation technique that maintains soil ecological and environmental services to the extent possible as well as search for alternative sustainable land uses. Controlled thermal desorption using a solar furnace at pilot scale was applied to different types of soils, stablishing the temperature necessary to assure the functionality of these soils and avoid the Hg exchange to the other environmental compartments. Soil mercury content evolution (total, soluble, and exchangeable) as temperature increases and induced changes in selected soil quality indicators are studied and assessed. On total Hg, the temperature at which it is reduced until acceptable levels depends on the intended soil use and on how restrictive are the regulations. For commercial, residential, or industrial uses, soil samples should be heated to temperatures higher than 280 °C, at which more than 80 % of the total Hg is released, reaching the established legal total Hg level and avoiding eventual risks derived from high available Hg concentrations. For agricultural use or soil natural preservation, conversely, maintenance of acceptable levels of soil quality limit heating temperatures, and additional treatments must be considered to reduce available Hg. Besides total Hg concentration in soils, available Hg should be considered to make final decisions on remediation treatments and potential future uses. Graphical Abstract Solar energy use for remediation of soils affected by mercury.

Oxidative stress in earthworms short- and long-term exposed to highly Hg-contaminated soils.

Exposure to mercury is often assessed by the measurement of molecular and biochemical antioxidant defences against an excessive production of reactive oxygen species. Here we examined some selected biomarkers of oxidative stress in the earthworm Lumbricus terrestris short- (2d) and long-term (44 d) exposed to Hg-contaminated soils (up to 1287 mg/kg dry wt). This level of Hg exposure did not cause earthworm mortality, however it yielded organisms to a situation of oxidative stress which was evidenced by the time-dependent responses of biomarkers. The reduced to oxidized glutathione ratio was a sensitive and early biomarker of Hg exposure, although the glutathione reductase activity back returned their normal physiological concentrations. Metallothioneins and total glutathione seemed to have a significant role in reducing Hg-induced oxidative stress when exposure to Hg prolonged up to 44 d. We combined biomarker responses into an integrate biomarker index which positively correlated with the Hg concentrations measured in the postmitochondrial fraction of the earthworm muscle, and with the available Hg fraction in soil. Current results suggest that glutathione redox cycle can be a complementary tool in the exposure and effect assessment of Hg-polluted soils.

Effect of a combination DNA vaccine for the prevention and therapy of Trypanosoma cruzi infection in mice: role of CD4+ and CD8+ T cells.

Chagas disease is a major public health problem, with about 10 million infected people, and DNA vaccines are a promising alternative for the control of Trypanosoma cruzi, the causing agent of the disease. We tested here a new DNA vaccine encoding a combination of two leading parasite antigens, TSA-1 and Tc24, for the prevention and therapy of T. cruzi infection. Immunized Balb/c mice challenged by T. cruzi presented a significantly lower parasitemia and inflammatory cell density in the heart compared to control mice. Similarly, the therapeutic administration of the DNA vaccine was able to significantly reduce the parasitemia and inflammatory reaction in acutely infected Balb/c and C57BL/6 mice, and reduced cardiac tissue inflammation in chronically infected ICR mice. Therapeutic vaccination induced a marked increase in parasite-specific IFNγ producing CD4(+) and CD8(+) T cells in the spleen as well as an increase in CD4(+) and CD8(+) T cells in the infected cardiac tissue. In addition, some effect of the DNA vaccine could still be observed in CD4-knockout C57BL/6 mice, which presented a lower parasitemia and inflammatory cell density, but not in CD8-deficient mice, in which the vaccine had no effect. These results indicate that the activation of CD8(+) T cells plays a major role in the control of the infection by the therapeutic DNA vaccine, and to a somewhat lesser extent CD4(+) T cells. This observation opens interesting perspectives for the potentiation of this DNA vaccine candidate by including additional CD8(+) T cell antigens/epitopes in future vaccine formulations.